Beta Drugs Q3 Results
- BSE: -
- NSE: BETA
- ISIN: INE351Y01019
- Sector: Biotechnology & Drugs
BSE
This stock is not traded on BSE
NSE
1,375.50
-11.10 (-0.80%)
-11.10 (-0.80%)Volume5.79 K
Updated: Fri 17 Apr, 2026 | 15:41:47
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
- Total Income--
- Operating Profit--
- Profit After Tax--
- Operating MarginNA%(NA%)
Note: Comparison is on YoY basis
Quarterly - Beta Drugs Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 22 | QoQ Comp |
|---|
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.